Namaste Technologies Inc.

N-X

Analysis and Opinions about N-X

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
October 17, 2018

He is hesitant to look into the social media companies related to the cannabis sector. He does not believe there is enough defensible on the technology side to say data gathering is a beneficial business in this space yet.

Show full opinionHide full opinion

He is hesitant to look into the social media companies related to the cannabis sector. He does not believe there is enough defensible on the technology side to say data gathering is a beneficial business in this space yet.

BUY
BUY
August 24, 2018

Likes how the company is set up. Poised to benefit with the way cannabis is rolling out. Value is going to be in the distribution. Not cheap, but none of the cannabis stocks are. A good company for sector exposure.

Show full opinionHide full opinion

Likes how the company is set up. Poised to benefit with the way cannabis is rolling out. Value is going to be in the distribution. Not cheap, but none of the cannabis stocks are. A good company for sector exposure.

TOP PICK
TOP PICK
June 19, 2018

This is positioning itself to become the Amazon and the Uber of the cannabis world, with 20 ecommerce sites across 20 countries. The stock had a huge runup because everyone was excited by the model, but it pulled back. This is a good time to get in. The company has $30 million in cash and will be doing further acquisitions. They have two unique platforms: One is for Namaste MD where patients can get prescriptions. The other, Cannmart, allows patients to buy cannabis online. Namaste will be one of the few licensees that sells cannabis but does not cultivate it. They are awaiting for Health Canada approval (Analyst’s price target is not provided)

Show full opinionHide full opinion

This is positioning itself to become the Amazon and the Uber of the cannabis world, with 20 ecommerce sites across 20 countries. The stock had a huge runup because everyone was excited by the model, but it pulled back. This is a good time to get in. The company has $30 million in cash and will be doing further acquisitions. They have two unique platforms: One is for Namaste MD where patients can get prescriptions. The other, Cannmart, allows patients to buy cannabis online. Namaste will be one of the few licensees that sells cannabis but does not cultivate it. They are awaiting for Health Canada approval (Analyst’s price target is not provided)

COMMENT
COMMENT
May 10, 2018

It is interesting in the way they have transitioned their business to cultivation. It is on his radar. It has some possibilities down the road.

Show full opinionHide full opinion

It is interesting in the way they have transitioned their business to cultivation. It is on his radar. It has some possibilities down the road.

Showing 1 to 4 of 4 entries
  • «
  • 1
  • »